MRVI
NASDAQStockMaravai LifeSciences Holdings, Inc.
$3.15-0.14 (-4.10%)
52-Week Range
$1.72
$4.02
Key Stats
Market Cap
455.3M
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.35
Volume
655.3K
Avg Volume
1.5M
Performance
1M
+5.45%
3M
-10.35%
6M
+20.96%
YTD
-3.24%
1Y
+35.95%
3Y
-78.76%
5Y
-91.45%
Price Chart
ETF Exposure
MRVI is held by 42 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| MSGR | Direxion mRNA ETF | 4.93% |
| QQQS | Invesco NASDAQ Future Gen 200 ETF | 0.47% |
| GNOM | Global X - Genomics & Biotechnology ETF | 0.28% |
| EBIT | Harbor AlphaEdge Small Cap Earners ETF (EBIT) | 0.09% |
| HEAL.L | iShares Healthcare Innovation UCITS ETF | 0.06% |
| STMB | iShares Trust - iShares Factors US Mid Blend Style ETF | 0.05% |
| IBBQ | Invesco Nasdaq Biotechnology ETF | 0.04% |
| PRFZ | Invesco RAFI US 1500 Small-Mid ETF | 0.04% |
| IBB | iShares Biotechnology ETF | 0.03% |
| IWN | iShares Russell 2000 Value ETF | 0.03% |
| BIB | ProShares - Ultra Nasdaq Biotechnology | 0.03% |
| VTWV | Vanguard Russell 2000 Value ETF | 0.03% |
| DFAS | Dimensional - US Small Cap ETF | 0.02% |
| RESM | Columbia Research Enhanced Small Cap ETF | 0.02% |
| IWM | iShares Russell 2000 ETF | 0.01% |
| VTWO | Vanguard Russell 2000 ETF | 0.01% |
| RSSL | Global X - Russell 2000 ETF | 0.01% |
| SCHA | Schwab U.S. Small-Cap ETF | 0.01% |
| UWM | ProShares - Ultra Russell2000 | 0.01% |
| URTY | ProShares - UltraPro Russell2000 | 0.01% |
| VHT | Vanguard Health Care ETF | 0.01% |
| VXF | Vanguard Extended Market ETF | 0.01% |
| SMMD | iShares Russell 2500 ETF | 0.00% |
| AVTM | Avantis Total Equity Markets ETF 1 | 0.00% |
| HDG | ProShares - Hedge Replication ETF | 0.00% |
| DCOR | Dimensional - US Core Equity 1 ETF | 0.00% |
| ITOT | iShares Core S&P Total U.S. Stock Market ETF | 0.00% |
| IWV | iShares Russell 3000 ETF | 0.00% |
| SCHB | Schwab U.S. Broad Market ETF | 0.00% |
| VTI | Vanguard Total Stock Market ETF | 0.00% |
| DFAC | Dimensional - US Core Equity 2 ETF | 0.00% |
| DFAU | Dimensional - US Core Equity Market ETF | 0.00% |
| ITDB | iShares LifePath Target Date 2030 ETF | 0.00% |
| ITDC | iShares LifePath Target Date 2035 ETF | 0.00% |
| ITDD | iShares LifePath Target Date 2040 ETF | 0.00% |
| ITDE | iShares LifePath Target Date 2045 ETF | 0.00% |
| ITDF | iShares LifePath Target Date 2050 ETF | 0.00% |
| ITDG | iShares LifePath Target Date 2055 ETF | 0.00% |
| ITDH | iShares LifePath Target Date 2060 ETF | 0.00% |
| ITDI | iShares LifePath Target Date 2065 ETF | 0.00% |
| ITDJ | iShares LifePath Target Date 2070 ETF | 0.00% |
| VTHR | Vanguard Russell 3000 ETF | 0.00% |
About MRVI ETF Exposure
Maravai LifeSciences Holdings, Inc. (MRVI) is held by 42 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 455.3M, MRVI is a widely held institutional stock. The stock currently trades at $3.15. Investors can gain exposure to MRVI through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold MRVI, sorted by portfolio weight.